Effect of follistatin on rat liver regeneration and tumor growth after portal occlusion

Hepato-Gastroenterology

Volumn 52, Issue 63, 2005, Pages 833-838

  Fujii, Masahiko ^a   Ishikawa, Masashi ^a   Iuchi, Masahiro ^a   Tashiro, Seiki ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Follistatin; Hepatic resection; Hepatoma; Liver regeneration; Portal occlusion

Indexed keywords

ACTIVIN A; FOLLISTATIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; HEPATIC ARTERY LIGATION; LIVER CANCER; LIVER REGENERATION; LIVER RESECTION; LIVER WEIGHT; MALE; NONHUMAN; PORTAL VEIN OBSTRUCTION; PRIORITY JOURNAL; RAT; TUMOR GROWTH; VEIN LIGATION;

ACTIVINS; ANIMALS; CELL DIVISION; FOLLISTATIN; INHIBIN-BETA SUBUNITS; INJECTIONS, INTRAVENOUS; LIGATION; LIVER NEOPLASMS, EXPERIMENTAL; LIVER REGENERATION; MALE; PORTAL VEIN; RATS; TUMOR CELLS, CULTURED;

EID: 20644435822     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Higgins GM, Anderson RM: Experimental pathology of the liver. Arch Pathol 1931; 12:186-202.
2. Nakamura T, Nawa K, Ichihara, A: Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats. Biochem Biophys Res Commun 1984; 122:1450-1459.
3. Ishiki Y, Ohnishi H, Muto Y, Matsumoto K, Nakamura T: Direct evidence that hepatocyte growth factor is a hepatotorophic factor for liver regeneration and has a potent anti-hepatitis effect in vivo. Hepatology 1992; 16:1227.
4. Sporn MB, Roberts AB, Wakefield LM, de Crombrugghe B: Some recent advances in the chemistry and biology of transforming growth factor-beta. J Cell Biol 1987; 105:1039-1045.
5. Massague J: The transforming growth factor-β family. Annu Rev Cell Biol 1990; 6:597-641.
6. Russell WE, Coffey RJ Jr, Ouellette AJ, Moses HL: Type β transforming growth factor reversibly inhibits the early proliferative response to partial hepatectomy in the rat. Proc Natl Acad Sci USA 1988; 85:5126-5130.
7. Yasuda H, Mine T, Shibata H, Eto Y, Hasegawa Y, Takeuchi T, et al: Activin A: An autocrine inhibitor of initiation of DNA synthesis in rat hepatocytes. J Clin Invest 1993; 92:1491-1496.
8. Schwall RH, Robbins K, Jardieu P, Chang L, Terrell TG: Activin induces cell death in hepatocytes in vivo and in vitro. Hepatology 1993; 18:347-356.
9. Zhang YQ, Mashima H, Kanzaki M, Shibata H, Kojima I: Assessment of the role of activin A and transforming growth factor β in the regulation of AML12 cell growth. Hepatology 1997; 25:1370-1375.
10. Nakamura T, Takio K, Eto Y, Shibai H, Titani K, Sugino H: Activin-binding protein from rat ovary is follistatin. Science 1990; 247:836-838.
11. Kogure K, Omata W, Kanzaki M, Zhang YQ, Yasuda H, Mine T, et al: A single intraportal administration of follistatin accelerates liver regeneration in partially hepatectomized rats. Gastroenterology 1995; 108:1136-1142.
12. Kogure K, Zhang YQ, Kanzaki M, Omata W, Mine T, Kojima I: Intravenous administration of follistatin: Delivery to the liver and effect on liver regeneration after partial hepatectomy. Hepatology 1996; 24:361-366.
13. Kogure K, Zhang YQ, Shibata H, Kojima I: Immediate onset of DNA synthesis in remnant rat liver after 90% hepatectomy by an administration of follistatin. J Hepatol 1998; 29:977-984.
14. Marcowitz SD, Roberts AB: Tumor suppressor activity of the TGF-β pathway in human cancers. Cytokine Growth Factor Rev 1996; 1:93-102.
15. Wang J, Sun L, Myeroff L, Yang J, Liang J, Zborowska E, et al: Demonstration that mutation of the type II TGF-β receptor inactivates its tumor suppressor activity in replication error-positive colon carcinoma cells. J Biol Chem 1995; 270:22044-22049.
16. Rous P, Larimore LD: Relation of the portal blood to liver maintenance. J Exp Med 1920; 31:609-632.
17. Rozga J, Jeppsson B, Bengmark S: Portal branch ligation in the rat: re-evaluation of a model. Am J Pathol 1986; 125:300-308.
18. Shintani Y, Takada Y, Yamasaki R, Saito S: Radioimmunoassay for activin A / EDF: Method and measurement of immunoreactive activin A / EDF levels in various biological materials. J Immunol Meth 1991; 137:267-274.
19. Harada K, Shintani Y, Sakamoto Y, Wakatsuki M, Shitsukawa K, Saito S: Serum immunoreactive activin A levels in normal subjects and patients with various diseases. J Clin Endocrinol Metab 1996; 81:2125-2130.
20. Carmichael J, DeGraff WG, Gazdar AF, Minna JD, Mitchell JB: Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res 1987; 47:936-942.
21. Mosmann T: Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Meth 1983; 65:55-63.
22. Fujiwara K, Nagoshi S, Ohno A, Hirata K, Ohta Y, Mochida S, et al: Stimulation of liver growth by exogeneous human hepatocyte growth factor n normal and partially hepatectomized rats. Hepatology 1993; 18:1443-1449.
23. Vale W, Rivier J, Vaughan J, McMlintock R, Corrigan A, Woo W, et al: Purification and characterization of an FSH releasing protein from porcine ovarian follicular fluid. Nature 1986; 321:776-779.
24. Mather JP, Moore A, Li RH: Activins, inhibins and follistatins: Further thoughts on a growing family of regulators. Proc Soc Exp Biol Med 1997; 215:209-212.
25. Okada S, Maeba T, Maeda H, Tanaka S: Effect of percutaneous transhepatic right branch of portal vein embolization on inducing human hepatocyte growth factor and liver function thereafter. Jpn J Gastroenterol Surg 1995; 28:1005-1012.
26. Ishikawa M, Yamataka A, Kawamoto S, Balderson GA, Lynch SV: Hemodynamic changes in blood flow through the denervated liver in pigs. J Invest Surg 1995; 8:95-100.
27. Rocheleau B, Houle ER, Huet PM, Bilodeau M: Hepatic artery buffer response following left portal vein ligation: its role in liver tissue homeostasis. Am J Physiol 1999; 277:01000-1007.
28. De Jong KP, Brouwers MA, Hulus GA, Dam A, Bun JC, Wubbena AS, et al: Liver cell proliferation after hepatectomy in rats with liver metastases. Anal Quant Cytol Histol 1997; 20:59-68.
29. Mizutani J, Hiraoka T, Yamashita R, Miyauchi Y: Promotion of hepatic metastases by liver resection in the rat. Br J Cancer 1992; 65:794-797.
30. Braun L, Mead J E, Panzica M, Mikumo R, Bell GI, Fausto N: Transforming growth factor β mRNA increases during liver regeneration: A possible paracrine mechanism of growth regulation. Proc Natl Acad Sci USA 1988; 85:1539-1543.
31. Mashima H, Kanzaki M, Nobusawa R, Zhang YQ, Suzuki M, Mine T, et al: Derangements in the activin-follistatin system in hepatoma cells. Gastroenterology 1995; 108:834-840.